Could a Two-Drug combo supercharge weight loss?
NCT ID NCT06373146
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 27 times
Summary
This study looked at whether adding a new drug, mibavademab, to the existing weight-loss drug tirzepatide helps adults with obesity lose more weight than tirzepatide alone. About 392 participants took part over 74 weeks. The goal was to see if the combination leads to greater weight reduction.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CTI Clinical Research Center
Cincinnati, Ohio, 45212, United States
-
Diablo Clinical Research, Inc.
Walnut Creek, California, 94598, United States
-
Hassman Research Institute Marlton Site
Marlton, New Jersey, 08053, United States
-
Irvine Clinical Research
Irvine, California, 92614, United States
-
Juno Research
Houston, Texas, 77040, United States
-
Lillestol Research
Fargo, North Dakota, 58104, United States
-
Northwest Clinical Research Center
Bellevue, Washington, 98007, United States
-
Solaris Clinical Research
Meridian, Idaho, 83646, United States
-
South Texas Clinical Research
Corpus Christi, Texas, 78404, United States
-
Tandem Clinical Research
Marrero, Louisiana, 70072, United States
-
Velocity Clinical Research - New Orleans
New Orleans, Louisiana, 70119, United States
-
Velocity Clinical Research, Dallas
Dallas, Texas, 75230, United States
-
Velocity Clinical Research, Gardena
Gardena, California, 90247, United States
-
Velocity Clinical Research, Los Angeles
Los Angeles, California, 90017, United States
-
Velocity Clinical Research, North Hollywood
North Hollywood, California, 91606, United States
-
Velocity Clinical Research, Panorama City
Van Nuys, California, 91405, United States
-
Velocity Clinical Research, Santa Ana
Santa Ana, California, 92704, United States
Conditions
Explore the condition pages connected to this study.